IHH unit: The front facade of Pantai Hospital in Kuala Lumpur which is a unit of the IHH Healthcare group.
KUALA LUMPUR: A leading premium global healthcare provider, IHH Healthcare (IHH), is leading a minority investment in Singapore-based genomic medicine company Lucence as part of a US$20mil in Series A funding.
The investment is part of IHH’s collaboration with start-ups to deploy innovative and cutting-edge healthcare technology to enhance the patient experience, treatment and clinical outcomes across its network of 80 hospitals in 10 countries.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
